Itraconazole methoxy phenoxy Impurity

Itraconazole methoxy phenoxy Impurity is a structurally related synthetic byproduct arising from the methylation of the phenoxy ring in the parent antifungal drug itraconazole. It retains the core triazole-linked dihydroxybutenyl moiety but features a methoxy (-OCH3) substitution at the phenoxy aromatic ring, altering its lipophilicity and chromatographic behavior. This impurity forms during synthetic pathways involving electrophilic aromatic substitution or oxidative methylation steps. It serves as a critical HPLC reference standard for quantifying process-related impurities in itraconazole active pharmaceutical ingredient (API) batches.